Literature DB >> 22752161

Pseudomonas aeruginosa bacteriophage PA1Ø requires type IV pili for infection and shows broad bactericidal and biofilm removal activities.

Shukho Kim1, Marzia Rahman, Sung Yong Seol, Sang Sun Yoon, Jungmin Kim.   

Abstract

We isolated a new lytic Pseudomonas aeruginosa phage that requires type IV pili for infection. PA1Ø has a broad bactericidal spectrum, covering Gram-positive and Gram-negative bacteria, and can eradicate biofilm cells. PA1Ø may be developed as a therapeutic agent for biofilm-related mixed infections with P. aeruginosa and Staphylococcus aureus.

Entities:  

Mesh：

Year:  2012        PMID： 22752161      PMCID： PMC3416619          DOI： 10.1128/AEM.00648-12

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN： 0099-2240            Impact factor:   4.792


  19 in total

Review 1.  Bacteriophage therapy.

Authors:  A Sulakvelidze; Z Alavidze; J G Morris
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

2.  A colorimetric microtiter plate method for assessment of phage effect on Pseudomonas aeruginosa biofilm.

Authors:  Petar Knezevic; Olga Petrovic
Journal:  J Microbiol Methods       Date:  2008-03-14       Impact factor: 2.363

Review 3.  Ecology and evolution in microbial systems: the generation and maintenance of diversity in phage-host interactions.

Authors:  Christine M Jessup; Samantha E Forde
Journal:  Res Microbiol       Date:  2008-06-06       Impact factor: 3.992

4.  European regulatory conundrum of phage therapy.

Authors:  Gilbert Verbeken; Daniel De Vos; Mario Vaneechoutte; Maya Merabishvili; Martin Zizi; Jean-Paul Pirnay
Journal:  Future Microbiol       Date:  2007-10       Impact factor: 3.165

5.  Characterization of the lysogenic repressor (c) gene of the Pseudomonas aeruginosa transposable bacteriophage D3112.

Authors:  K A Salmon; O Freedman; B W Ritchings; M S DuBow
Journal:  Virology       Date:  2000-06-20       Impact factor: 3.616

Review 6.  Bacteriophage therapy: a revitalized therapy against bacterial infectious diseases.

Authors:  Shigenobu Matsuzaki; Mohammad Rashel; Jumpei Uchiyama; Shingo Sakurai; Takako Ujihara; Masayuki Kuroda; Masahiko Ikeuchi; Toshikazu Tani; Mikiya Fujieda; Hiroshi Wakiguchi; Shosuke Imai
Journal:  J Infect Chemother       Date:  2005-10       Impact factor: 2.211

7.  A signaling network reciprocally regulates genes associated with acute infection and chronic persistence in Pseudomonas aeruginosa.

Authors:  Andrew L Goodman; Bridget Kulasekara; Arne Rietsch; Dana Boyd; Roger S Smith; Stephen Lory
Journal:  Dev Cell       Date:  2004-11       Impact factor: 12.270

8.  Purification and characterization of VSH-1, a generalized transducing bacteriophage of Serpulina hyodysenteriae.

Authors:  S B Humphrey; T B Stanton; N S Jensen; R L Zuerner
Journal:  J Bacteriol       Date:  1997-01       Impact factor: 3.490

9.  Mini-D3112 bacteriophage transposable elements for genetic analysis of Pseudomonas aeruginosa.

Authors:  A Darzins; M J Casadaban
Journal:  J Bacteriol       Date:  1989-07       Impact factor: 3.490

10.  Pseudomonas aeruginosa transposable bacteriophages D3112 and B3 require pili and surface growth for adsorption.

Authors:  C Roncero; A Darzins; M J Casadaban
Journal:  J Bacteriol       Date:  1990-04       Impact factor: 3.490
View more
  22 in total

Review 1.  Mechanisms and Targeted Therapies for Pseudomonas aeruginosa Lung Infection.

Authors:  Colleen S Curran; Thomas Bolig; Parizad Torabi-Parizi
Journal:  Am J Respir Crit Care Med       Date:  2018-03-15       Impact factor: 21.405

Review 2.  More than a feeling: microscopy approaches to understanding surface-sensing mechanisms.

Authors:  Katherine J Graham; Lori L Burrows
Journal:  J Bacteriol       Date:  2020-10-19       Impact factor: 3.490

Review 3.  Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics.

Authors:  Shugang Qin; Wen Xiao; Chuanmin Zhou; Qinqin Pu; Xin Deng; Lefu Lan; Haihua Liang; Xiangrong Song; Min Wu
Journal:  Signal Transduct Target Ther       Date:  2022-06-25

Review 4.  Current knowledge in the use of bacteriophages to combat infections caused by Pseudomonas aeruginosa in cystic fibrosis.

Authors:  María José Martínez-Gallardo; Claudia Villicaña; Martha Yocupicio-Monroy; Sofía Lizeth Alcaraz-Estrada; Josefina León-Félix
Journal:  Folia Microbiol (Praha)       Date:  2022-08-05       Impact factor: 2.629

Review 5.  Landmark Discoveries and Recent Advances in Type IV Pilus Research.

Authors:  Pradip Kumar Singh; Janay Little; Michael S Donnenberg
Journal:  Microbiol Mol Biol Rev       Date:  2022-05-25       Impact factor: 13.044

6.  Characterization of novel virulent broad-host-range phages of Xylella fastidiosa and Xanthomonas.

Authors:  Stephen J Ahern; Mayukh Das; Tushar Suvra Bhowmick; Ry Young; Carlos F Gonzalez
Journal:  J Bacteriol       Date:  2013-11-08       Impact factor: 3.490

7.  Development of expanded host range phage active on biofilms of multi-drug resistant Pseudomonas aeruginosa.

Authors:  Abigail C Mapes; Barbara W Trautner; Kershena S Liao; Robert F Ramig
Journal:  Bacteriophage       Date:  2016-01-05

8.  Characterization of a Salmonella Enteritidis bacteriophage showing broad lytic activity against Gram-negative enteric bacteria.

Authors:  Shukho Kim; Sung-Hun Kim; Marzia Rahman; Jungmin Kim
Journal:  J Microbiol       Date:  2018-10-25       Impact factor: 3.422

9.  Investigation of a Large Collection of Pseudomonas aeruginosa Bacteriophages Collected from a Single Environmental Source in Abidjan, Côte d'Ivoire.

Authors:  Christiane Essoh; Libera Latino; Cédric Midoux; Yann Blouin; Guillaume Loukou; Simon-Pierre A Nguetta; Serge Lathro; Arsher Cablanmian; Athanase K Kouassi; Gilles Vergnaud; Christine Pourcel
Journal:  PLoS One       Date:  2015-06-26       Impact factor: 3.240

10.  Genome signature-based dissection of human gut metagenomes to extract subliminal viral sequences.

Authors:  Lesley A Ogilvie; Lucas D Bowler; Jonathan Caplin; Cinzia Dedi; David Diston; Elizabeth Cheek; Huw Taylor; James E Ebdon; Brian V Jones
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.